DCK and mantle cell lymphoma: Our data from the cell lines and primary MCL samples clearly demonstrate that acquired resistance of MCL cells to araC is associated with downregulation of mRNA and protein expression of DCK, enzyme of the nucleotide salvage pathway responsible for phosphorylation of most nucleoside analogs used in anti-cancer therapy.